Families of Spinal Muscular Atrophy - Pharmaceuticals & Healthcare - Deals and Alliances Profile by GlobalData

VIEWS: 9 PAGES: 17

More Info
									        Families of Spinal Muscular Atrophy - Pharmaceuticals & Healthcare - Deals
                                   and Alliances Profile
       Reference Code: GDPH195224D                                                                                                              Publication Date: JAN 2013

      Company Overview                                                                                        Key Facts
      Families of Spinal Muscular Atrophy (FSMA) is a healthcare service provider, based
                                                                                                              Families of Spinal Muscular Atrophy,
      in the US. The company provides treatment and cure for the spinal muscular atrophy
                                                                                                              Pharmaceuticals & Healthcare, Key Facts
      disease. Families of SMA has funded over $50 million of SMA research in three
      areas that include basic research, drug development and clinical trials. It is currently                 Web Address                            www.fsma.org
      funding three distinct drug discovery programs Quinazolines, Tetracyclines, Motor
                                                                                                               Revenue (US$ million)                                 NA
      neuron replacement and is focused on clinical stage drug development and therapy
      program of project cure SMA, stem cell therapy.                                                          Number of Employees                                   NA
                                                                                                               GlobalData

      Financial Deals Landscape
        Families of Spinal Muscular Atrophy, Pharmaceuticals &                            Families of Spinal Muscular Atrophy, Pharmaceuticals &
        Healthcare, Deals by Type, 2007 to YTD 2013                                       Healthcare, Deals By Year, 2007 to YTD 2013


                                                                                                                           2
                                                                                                          2


                                                                                           No. of Deals          1                 1        1
                                                                                                          1


                                                                                                                                                      0    0          0
                                                                                                          0
                                                                                                               2007       2008   2009      2010   2011    2012       YTD
                                                                                                                                                                     2013


                                                                                          Note: Deals include all announced pharmaceuticals & healthcare deals
         Note: Deals include all announced pharmaceuticals & healthcare deals from
                                                                                          from 2006 onwards, GlobalData
         2006 onwards, GlobalData


         Families of Spinal Muscular Atrophy, Pharmaceuticals &                           Families of Spinal Muscular Atrophy, Pharmaceuticals &
         Healthcare, Deals By Region, 2007 to YTD 2013                                    Healthcare, Deals By Therapy Area, 2007 to YTD 2013

                         6     5                                                                          6           5
          No. of Deals




                                                                                           No. of Deals




                         5                                                                                5
                         4                                                                                4
                         3                                                                                3
                         2                                                                                2
                         1              0         0        0         0                                    1                            0          0              0
                         0                                                                                0
                             North    Asia-     Europe   Middle   South                                          Central         Cardiova Metabolic       Pharmac
                             Americ   Pacific             East     and                                           Nervous          scular  Disorder         euticals
                               a                          and     Central                                        System                       s              and
                                                         Africa   Americ                                                                                  Healthcar
                                                                    a                                                                                         e



         Note: Deals include all announced pharmaceuticals & healthcare deals             Note: Deals include all announced pharmaceuticals & healthcare deals
         from 2006 onwards, GlobalData                                                    from 2006 onwards, GlobalData




Families of Spinal Muscular Atrophy - Pharmaceuticals &                                                                                           Reference Code: GDPH195224D
Healthcare - Deals and Alliances Profile
Source : www.globalcompanyintelligence.com                                                                                                                                   Page 1
© GlobalData. This report is a licensed product and is not to be copied, reproduced, shared or resold in any form
       Table of Contents
       Table of Contents ............................................................................................................................................................................... 2
          List of Tables .................................................................................................................................................................................. 3
          List of Figures ................................................................................................................................................................................. 3
       Families of Spinal Muscular Atrophy, Pharmaceuticals & Healthcare, Deals By Year, 2007 to YTD 2013 ........................................ 3
       Families of Spinal Muscular Atrophy, Pharmaceuticals & Healthcare Deals By Type, 2007 to YTD 2013 ......................................... 5
       Families of Spinal Muscular Atrophy, Pharmaceuticals & Healthcare, Deals By Region, 2007 to YTD 2013 ..................................... 6
       Families of Spinal Muscular Atrophy, Pharmaceuticals & Healthcare, Deals By Therapy Area, 2007 to YTD 2013 .......................... 7
       Families of Spinal Muscular Atrophy, Pharmaceuticals & Healthcare, Deals Summary, 2007 to YTD 2013 ...................................... 8
       Families of Spinal Muscular Atrophy, Pharmaceuticals & Healthcare, Deal Details ........................................................................... 9
          Partnerships.................................................................................................................................................................................... 9
             Families of Spinal Muscular Atrophy Enters Into Collaboration Agreement With The Kaspar Lab .............................................. 9
             Paratek Pharma Expands Co-development Agreement With Families of Spinal Muscular Atrophy.......................................... 10
             FSMA, University of California Enters Into Co-development Agreement With California Stem Cell .......................................... 11
             Paratek Pharma Extends Co-Development Agreement With Families of Spinal Muscular Atrophy .......................................... 12
          Licensing Agreements .................................................................................................................................................................. 13
             Repligen Enters Into Licensing Agreement With Families of Spinal Muscular Atrophy ............................................................. 13
       Families of Spinal Muscular Atrophy - Key Competitors ................................................................................................................... 14
       Key Employees ................................................................................................................................................................................ 15
       Locations And Subsidiaries .............................................................................................................................................................. 16
          Head Office ................................................................................................................................................................................... 16
       Appendix .......................................................................................................................................................................................... 17
          Methodology ................................................................................................................................................................................. 17
          About GlobalData ......................................................................................................................................................................... 17
          Contact Us .................................................................................................................................................................................... 17
          Disclaimer ..................................................................................................................................................................................... 17




Families of Spinal Muscular Atrophy - Pharmaceuticals &                                                                                                          Reference Code: GDPH195224D
Healthcare - Deals and Alliances Profile
Source : www.globalcompanyintelligence.com                                                                                                                                                                Page 2
© GlobalData. This report is a licensed product and is not to be copied, reproduced, shared or resold in any form
       List of Tables
       Families of Spinal Muscular Atrophy, Pharmaceuticals & Healthcare, Key Facts .............................................................................. 1
       Families of Spinal Muscular Atrophy, Pharmaceuticals & Healthcare, Deals By Year, 2007 to YTD 2013 ........................................ 1
       Families of Spinal Muscular Atrophy, Pharmaceuticals & Healthcare, Deals By Region, 2007 to YTD 2013 ..................................... 1
       Families of Spinal Muscular Atrophy, Pharmaceuticals & Healthcare, Deals By Therapy Area, 2007 to YTD 2013 .......................... 1
       Families of Spinal Muscular Atrophy, Pharmaceuticals & Healthcare, Deals By Year, 2007 to YTD 2013 ........................................ 4
       Families of Spinal Muscular Atrophy, Pharmaceuticals & Healthcare Deals By Type, 2007 to YTD 2013 ......................................... 5
       Families of Spinal Muscular Atrophy, Pharmaceuticals & Healthcare, Deals By Region, 2007 to YTD 2013 ..................................... 6
       Families of Spinal Muscular Atrophy, Deals By Therapy Area, 2007 to YTD 2013 ............................................................................ 7
       Families of Spinal Muscular Atrophy, Pharmaceuticals & Healthcare, Deals Summary, 2007 to YTD 2013 ...................................... 8
       Families of Spinal Muscular Atrophy Enters Into Collaboration Agreement With The Kaspar Lab ..................................................... 9
       Paratek Pharma Expands Co-development Agreement With Families of Spinal Muscular Atrophy ................................................. 10
       FSMA, University of California Enters Into Co-development Agreement With California Stem Cell ................................................. 11
       Paratek Pharma Extends Co-Development Agreement With Families of Spinal Muscular Atrophy ................................................. 12
       Repligen Enters Into Licensing Agreement With Families of Spinal Muscular Atrophy .................................................................... 13
       Families of Spinal Muscular Atrophy, Key Competitors .................................................................................................................... 14
       Families of Spinal Muscular Atrophy, Key Employees ..................................................................................................................... 15


       List of Figures
       Families of Spinal Muscular Atrophy, Pharmaceuticals & Healthcare, Deals by Type, 2007 to YTD 2013 ........................................ 1
       Families of Spinal Muscular Atrophy, Pharmaceuticals & Healthcare, Deals By Year, 2007 to YTD 2013 ........................................ 4
       Families of Spinal Muscular Atrophy, Pharmaceuticals & Healthcare, Deals by Type, 2007 to YTD 2013 ........................................ 5
       Families of Spinal Muscular Atrophy, Pharmaceuticals & Healthcare, Deals By Region, 2007 to YTD 2013 ..................................... 6
       Families of Spinal Muscular Atrophy, Pharmaceuticals & Healthcare, Deals By Therapy Area, 2007 to YTD 2013 .......................... 7




Families of Spinal Muscular Atrophy - Pharmaceuticals &                                                                                      Reference Code: GDPH195224D
Healthcare - Deals and Alliances Profile
Source : www.globalcompanyintelligence.com                                                                                                                                      Page 3
© GlobalData. This report is a licensed product and is not to be copied, reproduced, shared or resold in any form
       Families of Spinal Muscular Atrophy, Pharmaceuticals & Healthcare, Deals By Year, 2007
       to YTD 2013


       Families of Spinal Muscular Atrophy, Pharmaceuticals & Healthcare, Deals By Year, 2007 to YTD 2013


                                                  3                                                                            20


                                                                       16.00

                                                                                                                               15
                                                                2




                                                                                                                                     Deal Value (US$ million)
                                                  2
                                   No. of Deals




                                                                                                                               10


                                                       1                  1         1
                                                  1

                                                                                                                               5




                                                                                              
								
To top